MATA NATHAN L.
Chief Scientific Officer
All tracked transactions
Curated subset of MATA NATHAN L.'s SEC Form 4 filings. Routine 10b5-1 schedule sales are flagged inline and weighted less in the conviction score.
| Date | Ticker | Action | Value |
|---|---|---|---|
| Apr 20, 2026 | BLTE | sell | $2K 9 × $168.35 |
| Apr 20, 2026 | BLTE | sell | $3K 16 × $167.165 |
| Apr 20, 2026 | BLTE | sell | $500.715 3 × $166.905 |
| Apr 20, 2026 | BLTE | sell | $7K 40 × $165.2935 |
| Apr 20, 2026 | BLTE | sell | $20K 124 × $164.4009 |
| Apr 20, 2026 | BLTE | sell | $86K 524 × $163.5193 |
| Apr 20, 2026 | BLTE | sell | $46K 284 × $162.7552 |
| Apr 20, 2026 | BLTE | sell | $2K 9 × $168.35 |
| Apr 20, 2026 | BLTE | sell | $3K 16 × $167.165 |
| Apr 20, 2026 | BLTE | sell | $500.715 3 × $166.905 |
| Apr 20, 2026 | BLTE | sell | $7K 40 × $165.2935 |
| Apr 20, 2026 | BLTE | sell | $20K 124 × $164.4009 |
| Apr 20, 2026 | BLTE | sell | $86K 524 × $163.5193 |
| Apr 20, 2026 | BLTE | sell | $46K 284 × $162.7552 |
| Apr 17, 2026 | BLTE | sell | $33K 200 × $163.325 |
| Apr 17, 2026 | BLTE | sell | $35K 216 × $162.4833 |
| Apr 17, 2026 | BLTE | sell | $44K 274 × $161.4092 |
| Apr 17, 2026 | BLTE | sell | $36K 226 × $160.5474 |
| Apr 17, 2026 | BLTE | sell | $8K 52 × $159.3838 |
| Apr 17, 2026 | BLTE | sell | $5K 32 × $158.4563 |
| Apr 17, 2026 | BLTE | sell | $33K 200 × $163.325 |
| Apr 17, 2026 | BLTE | sell | $35K 216 × $162.4833 |
| Apr 17, 2026 | BLTE | sell | $44K 274 × $161.4092 |
| Apr 17, 2026 | BLTE | sell | $36K 226 × $160.5474 |
| Apr 17, 2026 | BLTE | sell | $8K 52 × $159.3838 |
| Apr 17, 2026 | BLTE | sell | $5K 32 × $158.4563 |
| Apr 16, 2026 | BLTE | sell | $2K 12 × $164.1233 |
| Apr 16, 2026 | BLTE | sell | $6K 36 × $163.2111 |
| Apr 16, 2026 | BLTE | sell | $12K 76 × $162.2638 |
| Apr 16, 2026 | BLTE | sell | $39K 240 × $161.6097 |
| Apr 16, 2026 | BLTE | sell | $32K 201 × $160.3475 |
| Apr 16, 2026 | BLTE | sell | $35K 219 × $159.8132 |
| Apr 16, 2026 | BLTE | sell | $34K 216 × $158.2784 |
| Apr 16, 2026 | BLTE | sell | $2K 12 × $164.1233 |
| Apr 16, 2026 | BLTE | sell | $6K 36 × $163.2111 |
| Apr 16, 2026 | BLTE | sell | $12K 76 × $162.2638 |
| Apr 16, 2026 | BLTE | sell | $39K 240 × $161.6097 |
| Apr 16, 2026 | BLTE | sell | $32K 201 × $160.3475 |
| Apr 16, 2026 | BLTE | sell | $35K 219 × $159.8132 |
| Apr 16, 2026 | BLTE | sell | $34K 216 × $158.2784 |
Method
Conviction score = logistic(role_weight × (buy_value − 0.2 × discretionary_sell_value)) mapped to −100..+100. CEOs and founders carry role_weight 0.95-1.0; directors 0.5; former executives 0.3. Routine 10b5-1 schedule sales are weighted down sharply — insiders file pre-arranged selling plans that trigger independent of their view of the stock, so they carry minimal signal. Open-market discretionary buys are rare and carry the heaviest weight.
Role weight: 0.40 (Chief Scientific Officer).
Data sourced from SEC Form 4 filings via EDGAR. Curated subset (not every filing) — we prioritize CEO/CFO/Chair/10%-owner transactions and material $ amounts over noise.
Tickers MATA has traded
SEC Form 4 filings disclose trades by corporate insiders within 2 business days. Conviction scoring is a synthesis — not investment advice.